During a press conference at the White House, Novo Nordisk executive Gordon Findlay unexpectedly collapsed while standing behind President Donald Trump. The event was held to announce a new deal on weight-loss medications.
Suddenly, Findlay's knees gave way, causing him to buckle. Administration officials and pharmaceutical representatives quickly intervened to prevent him from falling to the floor.
White House Press Secretary Karoline Leavitt addressed the incident, explaining it occurred during the "Most Favored Nations Oval Office Announcement." According to her:
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
Medical staff on-site provided swift care, ensuring Findlay was stable. The press conference was paused briefly but resumed normally soon after.
Press witnesses reported that Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, helped Findlay gently to the ground, preventing head injury. Reporters were then asked to leave the Oval Office while cabinet members assisted Findlay by elevating his legs.
The sudden collapse highlighted the quick response of officials and medical staff during the announcement, ensuring the executive received immediate care without disruption.
“The White House Medical Unit quickly jumped into action, and the gentleman is okay.” – Karoline Leavitt
Author's note: Swift intervention by officials ensured a medical emergency was effectively handled without major disruption during the White House event.